Indegene Limited
ListedMainboardHealthcare / Life Sciences · NSE / BSE
Founded in 1998, Indegene Limited is a leading digital solutions provider for the life sciences industry, helping companies with everything from drug development and clinical trials to regulatory submissions and sales & marketing. The company offers a wide range of services through its Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Enterprise Clinical Solutions, along with expert consultancy. Its subsidiary, DT Consulting, specializes in guiding life sciences firms through digital transformation to enhance customer experiences. Indegene has also been recognized for its workplace excellence, winning the Platinum Level award at the 2023 Healthy Workplace Conference and Awards. With a global team of 5,181 professionals and 65 active clients across India, North America, Europe, China, and beyond, Indegene continues to deliver innovative and impactful solutions for the life sciences sector.
Price Band
₹430 – ₹452
Issue Size
₹1842 Cr
Lot Size
33 shares
GMP
₹275
+60.8%
Est. Listing
₹727
at current GMP
Subscribed
70.26x
overall
Open
6 May 2024
Close
8 May 2024
Allotment
10 May 2024
Refund
11 May 2024
Demat Credit
12 May 2024
Listing
13 May 2024
Last updated 12 days ago
Overall Subscription
70.26x
Total Demand
QIB Multiplier
192.72x
Institutions & Funds
NII / HNI
55.84x
High Net-Worth
Retail (RII)
7.80x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 8,094,068 | 1,559,865,945 | 192.72x |
| NIB | 6,070,552 | 338,981,940 | 55.84x |
| HNIs(10L +) | 4,047,035 | 251,864,613 | 62.23x |
| HNIs (2-10L) | 2,023,517 | 87,117,327 | 43.05x |
| RETAIL | 14,164,620 | 110,421,729 | 7.80x |
| EMPLOYEES | 296,208 | 1,949,739 | 6.58x |
| Total | 34,696,000 | 2,350,201,293 | 70.26x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| HNIs(10L +) | 8,760 | 108,020 | 12.33x |
| HNIs (2-10L) | 4,380 | 178,974 | 40.86x |
| RETAIL | 429,231 | 2,493,188 | 5.81x |
| Total Applications | 442,371 | 2,780,182 | 6.28x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Indegene Limited Public Issue & Market Profile
Indegene Limited is bringing an initial public offering (IPO) in the Healthcare / Life Sciences sector with an aggregate issue size of ₹1,841.76 Crores. The shares are offered at a price band of ₹430 to ₹452 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 33 shares (approx. ₹14,916 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-05-12, while un-allotted funds or UPI block mandates will be released on 2024-05-11.
Frequently Asked Questions
What is Indegene Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Indegene Limited IPO is ₹275 per equity share. Based on the upper price band of ₹430 to ₹452 per equity share, the estimated listing price is ₹727 (+60.8% expected listing gain).
What is the expected profit per lot for Indegene Limited IPO?
With a lot size of 33 shares and current GMP of ₹275, the expected profit per application lot is approx ₹9,075 (+60.8% gain). Minimum application cost is approx ₹14,916.
What is the issue size and price band for Indegene Limited IPO?
The Indegene Limited IPO aggregate issue size is ₹1,841.76 Crores with an equity price band set at ₹430 to ₹452 per equity share. The retail lot size is 33 shares requiring a minimum capital outlay of approx. ₹14,916.
How can I check Indegene Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 70.26x (Retail: 7.80x, QIB: 192.72x, NII: 55.84x). You can track live multiples directly on our dedicated subscription page.
Where and when will Indegene Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2024-05-10. Investors can verify status using PAN card or application number.
When is the listing date for Indegene Limited IPO?
Indegene Limited shares are scheduled to list on NSE and BSE on 2024-05-13.